Drug Profile
FF 1027T
Alternative Names: FF-1027TLatest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator FUJIFILM Corporation
- Class Antineoplastics
- Mechanism of Action Bromodomain and extraterminal domain protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Haematological malignancies; Solid tumours
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for preclinical development in Haematological-malignancies in Japan (IV)
- 28 Nov 2021 No recent reports of development identified for preclinical development in Haematological-malignancies in Japan (PO)
- 28 Nov 2021 No recent reports of development identified for preclinical development in Solid-tumours in Japan